Design Therapeutics, Inc.
DSGN
$15.62
-$0.17-1.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -6.49% | 10.43% | 22.84% | 49.66% | 56.89% |
| Gross Profit | 6.49% | -10.43% | -22.84% | -49.66% | -56.89% |
| SG&A Expenses | 5.67% | 4.56% | 8.05% | 28.80% | 9.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.49% | 8.84% | 18.87% | 43.38% | 41.79% |
| Operating Income | 3.49% | -8.84% | -18.87% | -43.38% | -41.79% |
| Income Before Tax | 0.45% | -17.19% | -30.36% | -61.82% | -59.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.45% | -17.19% | -30.36% | -61.82% | -59.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.45% | -17.19% | -30.36% | -61.82% | -59.52% |
| EBIT | 3.49% | -8.84% | -18.87% | -43.38% | -41.79% |
| EBITDA | 3.50% | -8.87% | -19.03% | -43.82% | -42.10% |
| EPS Basic | 8.01% | -13.12% | -29.57% | -60.96% | -58.75% |
| Normalized Basic EPS | 8.05% | -13.09% | -29.60% | -61.01% | -58.75% |
| EPS Diluted | 8.01% | -13.12% | -29.57% | -60.96% | -58.75% |
| Normalized Diluted EPS | 8.05% | -13.09% | -29.60% | -61.01% | -58.75% |
| Average Basic Shares Outstanding | 8.24% | 3.62% | 0.58% | 0.54% | 0.48% |
| Average Diluted Shares Outstanding | 8.24% | 3.62% | 0.58% | 0.54% | 0.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |